-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Acurx Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate for Q1 2022.
- Acurx Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000.
- Acurx Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)